Michael Fenn

Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA.

Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA.

The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.

Myolex, Inc. fitness tracker provider. It develops hardware and software to accurately measure total body composition, as well as the fat content and muscle quality for specific body parts. The company was founded in 2009 by Seward Rutkove and Jose Bohorquez and is headquartered in San Francisco, CA.

Saphetor SA develops software and analytical processes using proprietary algorithms and trade secret know-how to identify genetic variants. Its services include data-driven solutions, accurate diagnoses, and informed decisions for the selection of the best therapies, especially for cancer and difficult to diagnose conditions, such as rare diseases or cognitive impairment. The company was founded by Andreas Massouras in 2014 and is headquartered in Lausanne, Switzerland.

monARC Bionetworks, Inc. operates as a healthcare technology company. The firm manages the data of the patients to therapy development models into integrated and collaborative endeavors with patients at the center. The company was founded by Komathi Stem and is headquartered in San Francisco, CA.

Celeri Health, Inc. provides a reimbursable, caregiver-centric, patient-reported outcomes data capture system. Its solution helps clinicians to determine the right therapy for the right person at the right time. The company was founded by Michael Fishman and Jason Pope in 2018 and is headquartered in Paoli, PA.

Psy Therapeutics, Inc. develops novel medicines for central nervous system disorders. The firm focuses on anxiety, depression and dementia. The company was founded by Brant Binder, Maurizio Fava, Roy Perlis and Jerry Rosenbaum and is headquartered in Boston, MA.

Pragma Biosciences, Inc. is a drug discovery company that mines the microbiome for potential drug candidates. The company is headquartered in San Carlos, CA.

Altimate Health Corp. provides psychiatric treatment services.

Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation.

Quantori LLC is an end-to-end digital IT service provider for the life science and healthcare industries. Quantori is based in Cambridge, MA, and the CEO of the company is Richard Golob. The company specializes in providing customized scientific informatics solutions to accelerate target and drug discovery. The company's expertise allows them to automate, analyze, and digitally transform to gain a competitive advantage.

Zafrens, Inc. is an American company that is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. Zafrens is based in California. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company's mission is to unlock the full story of every cell to accelerate drug discovery. The CEO of the company is Kandaswamy Vijayan.